Thomas Putz

Title: The Innovative Contributions of Thomas Putz

Introduction

Thomas Putz is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Putz has focused on developing solutions for cancer treatment and immunization.

Latest Patents

Putz's latest patents include an immunogenic recombinant antibody designed for the immunization of primates. This invention comprises at least a part of a murine IgG2a subtype amino acid sequence and a mammalian glycosylation. Another significant patent involves the use of a preparation based on an antibody directed against a tumor-associated glycosylation. This invention aims to prepare a medicament for the prophylactic and therapeutic treatment of tumor cell growth in cancer patients. It also includes a pharmaceutical preparation containing the antibody, a diagnostic method, and an agent for determining the risk of metastasis formation in cancer patients.

Career Highlights

Throughout his career, Thomas Putz has worked with various companies, including Igeneon Krebs-Immuntherapie Forschungs-Und Entwicklungs-Ag and Altropus GmbH. His work has been instrumental in advancing cancer treatment methodologies and immunological research.

Collaborations

Putz has collaborated with notable professionals in his field, including Gottfried Himmler and Hans Loibner. These collaborations have contributed to the development of his innovative patents and research.

Conclusion

Thomas Putz's contributions to immunology and cancer treatment through his patents highlight his role as a significant inventor in the field. His work continues to influence advancements in medical science and patient care.